Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02674308 · ClinicalTrials.gov registry record
Entyvio (Vedolizumab) Long Term Safety Study
A clinical trial, sponsored by Takeda.
- Completed
- Registry status
- 5,302
- Enrollment target
NCT02674308 is a clinical trial that has completed, run by Takeda. The registered enrollment target is 5,302 participants.
The verdict
NCT02674308 has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- 5,302 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).
Interventions
- DRUG Vedolizumab
- OTHER Other Biologic Agents
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,302 participants |
| Start Date | 2015-03-24 |
| Est. Completion | 2021-07-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02674308
The ClinicalTrials.gov registry entry for NCT02674308 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vedolizumab is the first listed.
NCT02674308 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02674308 about?
NCT02674308 is a clinical study titled "Entyvio (Vedolizumab) Long Term Safety Study". The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis (UC) or Crohn's Disease (CD).
What is the current status of trial NCT02674308?
This trial is currently completed. The enrollment target is 5,302 participants. The study started on 2015-03-24. Estimated completion is 2021-07-30.
What interventions are being tested in trial NCT02674308?
The interventions under investigation include: Vedolizumab (DRUG), Other Biologic Agents (OTHER).
Who is sponsoring clinical trial NCT02674308?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.